The global epidemic of HIV/AIDS has led to unprecedented attention and commitment from governmements and the international community to improve access to HIV prevention and treatment. The need to better document the effectiveness of HIV prevention programmes and to do this with the most robust methods possible is widely recognized. The analyses of district-level or national HIV prevention programmes targeted at various groups at-risk are often based on listing prevention interventions with little indication about their scale, reach, coverage and quality.
The aim of this course is to provide participants with practical guidance on how to design and carry out evaluation of HIV programmes in groups at higher risk of HIV, and how to conduct the evaluation of larger-scale HIV prevention interventions.
The course starts with introductory presentations on HIV monitoring and evaluation (M&E) which describe the key concepts such as M&E framework, components of the M&E system and indicators used to assess performance of HIV programmes.
The course will further outline through case examples how to conduct monitoring and evaluation of specific programmes such as anti-retroviral treatment (ART) programmes, and HIV prevention in injecting drug users (IDUs) and female sex workers (FSW) and their clients. Presentations on evaluation of HIV interventions in IDUs, FSW and clients will start with an outline of the components of the comprehensive package for HIV prevention in these groups, which are consequently the subject of the evaluation through assessment of their availability, coverage, quality and potential impact. Documenting the types of programme components that were provided and their coverage and quality gives information not only on whether the interventions had an impact, but also about how the effect was obtained. Therefore, constructing a clear programme impact pathways is not only a part of the programme design but also provides the basis for strong evaluation.
Participants will also learn the principles of conducting HIV data triangulation, which is defined as a synthesis and integration of data from multiple data sources in order to answer different question, ranging from explaining the trends and the levels of the HIV epidemic to assessing the population impact of HIV prevention and treatment programmes.
Key Topics of the Course
- Basic principles and concepts of M&E
- Input, process, output, outcome and impact indicators
- Methods used to design monitoring and evaluation studies (routine data collection, cross-sectional studies, cohort studies, randomized control trials, stepped-wedge design)
- Monitoring and evaluation of ART programmes, including core pre-ART and ART patient monitoring indicators, simple cohort analysis, HIV drug resistance early warning indicators
- Components of comprehensive HIV prevention programmes in IDUs, and monitoring and evaluation of HIV prevention in IDUs (with case studies)
- Components of comprehensive HIV prevention programmes in FSW and clients of FSW, , and monitoring and evaluation of HIV prevention (with case studies)
- Using HIV data triangulation to evaluate HIV prevention programmes at regional and national level (data collection and principles of data analysis)
The course consists of lectures, exercises and case studies. It is designed to provide participants with practical skills and knowledge in monitoring and evaluation of various components of comprehensive HIV prevention programmes at the service delivery and regional/ national level.
An important part of the course is a group or individual work during which participants will develop protocols for evaluation of HIV programmes or projects. Participants are encouraged to work on a protocol which they can later on use in their countries. The protocols will be presented by participants during the final day of the workshop.
Professionals working on planning, implementation and evaluation of HIV prevention and treatment programmes.
Duration and site
The course takes place in five days.
- Ivana Bozicevic, MD, DrPH, WHO Collaborating Centre for HIV Surveillance, School of Medicine, University of Zagreb, Croatia
- Aleksandar Štulhofer. PhD, Department of Sociology, University of Zagreb
- Jurja-Ivana Cakalo, MD, WHO Collaborating Centre for HIV Surveillance, School of Medicine, University of Zagreb, Croatia
- Senad Handanagić, MD WHO Collaborating Centre for HIV Surveillance, School of Medicine, University of Zagreb, Croatia